Designing a More Accurate Protein Census

Graphic: Leza BerardoneApplied Biosystems will soon begin testing new mass spectrometry machines designed to identify proteins in as many as 1,000 samples per hour. For the machines to work as planned, however, each sample must be prefractionated down to just a handful of proteins, according to Stephen A. Martin, director of the company's proteomics research center in Framingham, Mass. This example suggests how the slower protocols leading to mass spec are as important to the progress of proteom

Written byDouglas Steinberg
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

These protocols have a serious limitation. Just as the Census Bureau's methods lead to the undercounting of certain population groups, the protocols lead researchers to under-identify whole classes of proteins. But clever strategies to attack this problem are starting to appear. Two papers published this month unveil chemistry-based methods that help recognize phosphorylated proteins.1,2 And a paper published last month presented a process to uncover many traditionally overlooked proteins.3

Phosphorylation is a central event in many biological processes, so why are researchers only now finding ways to study it proteomically? "One now has fast, effective mass spectrometric ways for identifying proteins that really only matured in the last few years," says Brian T. Chait, director of the mass spectrometry and gaseous ion chemistry lab at Rockefeller University and senior author of one of this month's papers.1 Ruedi Aebersold, senior author of the other paper2 and a professor at the Institute ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies